NSU Newsroom
SharkBytes
Horizons
This version of NSU News has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of NSU News, visit news.nova.edu.
This version of SharkBytes has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of SharkBytes, visit sharkbytes.nova.edu.
NSU Institute for Neuro-Immune Medicine Hosts Monthly Seminar, May 4
The INIM is pleased to host William Loging, Ph.D., at the monthly INIM Research Seminar Series on Friday, May 4, 2018 from 12:00–1:30 p.m. at the Center for Collaborative Research (CCR) on the 2nd floor, room 242.
Loging has spent the past 20 years focusing on generating treatments for human disease. Bridging genomics, informatics, and pharmaceutical sciences, he has been globally recognized for his work with maraviroc (Selzentry™) for treating HIV.
The results of past contributions to the approval of empagliflozin (Jardiance™) for diabetes were listed within the drug insert. His most recent work on Il-23 use in autoimmune disease (risankizumab) was licensed to AbbVie for more than $500M. Loging has published in several leading scientific journals on the utilization of novel informatics approaches to drug discovery and his 2014 TEDx talk on cancer genomics was highly acclaimed. He is currently director of science and head of Gateway Institute for Brain Research. His most recent book on the science of drug discovery is a blueprint for future success in the field.
Join us as he lectures on “A Journey within Pharmaceutical Sciences.” You won’t want to miss it! These seminars are scheduled to be broadcast to regional campuses upon request.
RSVP at your earliest convenience.